Denali(DNLI) - 2024 Q4 - Annual Results

Exhibit 1.2 DENALI THERAPEUTICS INC. Common Stock ($0.01 par value) Having an Aggregate Offering Price of up to$400,000,000 Equity Distribution Agreement February 27, 2025 Goldman, Sachs & Co. LLC 200 West Street New York, New York 10282 Leerink Partners LLC 1301 Avenue of the Americas, 5 Floor New York, New York 10019 th Ladies and Gentlemen: Denali Therapeutics Inc., a Delaware corporation (the "Company") confirms its agreement (this "Agreement") with Goldman, Sachs & Co. LLC ("Goldman") and Leerink Part ...